Work

Potential factors influencing initial sorafenib dose selection in hepatocellular carcinoma (HCC): U.S. regional analysis of GIDEON.

Year: 2014

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2014.32.3_suppl.304

Authors: Bilal Piperdi, Allen Lee Cohn, Anthony B. El-Khoueiry, Jean-Francois Geschwind, Pierre Michel Gholam, Parvez Mantry, Robert C. G. Martin, Brendan McGuire, Rebecca A. Miksad, Arun J. Sanyal, Alan Paul Venook, Svetlana Babajanyan, Alec Goldenberg

Institutions: Montefiore Medical Center, Rocky Mountain Cancer Centers, USC Norris Comprehensive Cancer Center, Johns Hopkins University, University Hospitals Cleveland Medical Center, Methodist Dallas Medical Center, University of Louisville, University of Alabama at Birmingham, Beth Israel Deaconess Medical Center, Virginia Commonwealth University Medical Center, University of California, San Francisco, Bayer (United States), New York University

Language: English

Topic: Hepatocellular Carcinoma Treatment and Prognosis

Subfield: Hepatology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2587517259

Cites:

Cited by:

Related to: 10